Lineage Cell Therapeutics Inc (AMEX:LCTX) currently has a daily average trading volume of 1.52M but it saw 4015684 shares traded in last market. With a market cap of 208.97M USD, the company’s current market price of $0.92 came rising about 6.61 while comparing to the previous closing price of $0.86. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.15 and as low as $0.37. In the recent trading on the day, stock has struck highest price mark of $0.829 while lowest mark touched by it was $0.9297.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Craig Hallum which initiated the stock as “Buy” in its note to investors issued on August 20, 2024, recommending a price target of $4 for it. B. Riley Securities also issued its recommendations for the stock as it initiated the price target for the stock is $4.
Over the week, LCTX’s stock price is moving 30.64% up while it is 83.98% when we observe its performance for the past one month. Year-to-date it is 82.11% up and over the past year, the stock is showing a downside performance of -0.47%.
The company is expected to be releasing its next quarterly report on 2025-May-13, for which analysts forecasted an EPS of -0.03 while estimate for next year EPS is -0.1. In next quarter, company is expected to be making quarterly sales of $1.89M as analysts are expecting the sales for current fiscal year at $6.7M and seeing the company making $23.11M in sales next year. Moreover, analysts are in estimates of $1.47M for current-quarter revenue.
Currently, Lineage Cell Therapeutics Inc’s total number of outstanding shares is 228.36M. Company’s return on investment (ROI) stands at -20.23% and return on equity (ROE) at -21.40%. Stock’s beta reads 1.52. Stock has a price to book (P/B) ratio of 2.64 while price to sale or P/S ratio amounts to 21.86. Its return on asset (ROA) is -14.72% on average.
